JPMorgan Chase & Co. (JPM) 13D/13G Filings for Kyverna Therapeutics, Inc. (KYTX)

JPMorgan Chase & Co. 13D and 13G filings for Kyverna Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-10
12:36 pm
Purchase
2024-09-3013GKyverna Therapeutics, Inc.
KYTX
JPMORGAN CHASE & CO
JPM
2,380,021
5.500%
2,380,021increase
(New Position)
Filing